Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, providing promising progress throughout several healthcare and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA offers a safer, additional reputable option for therapeutic use, spe